Alexion nears $25M settlement with SEC in FCPA probe

Money

Alexion Pharmaceuticals said in a regulatory filing that it is nearing a $25 million settlement with the Securities and Exchange Commission concerning an investigation into the company’s compliance with the Foreign Corrupt Practices Act spanning various countries.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.